Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In Situ Raman Study of Neurodegenerated Human Neuroblastoma Cells Exposed to Outer-Membrane Vesicles Isolated from Porphyromonas gingivalis.
Pezzotti G, Adachi T, Imamura H, Bristol DR, Adachi K, Yamamoto T, Kanamura N, Marin E, Zhu W, Kawai T, Mazda O, Kariu T, Waku T, Nichols FC, Riello P, Rizzolio F, Limongi T, Okuma K. Pezzotti G, et al. Among authors: bristol dr. Int J Mol Sci. 2023 Aug 28;24(17):13351. doi: 10.3390/ijms241713351. Int J Mol Sci. 2023. PMID: 37686157 Free PMC article.
Treatment of Plaque-Type Psoriasis With Oral CF101: Data from a Phase II/III Multicenter, Randomized, Controlled Trial.
David M, Gospodinov DK, Gheorghe N, Mateev GS, Rusinova MV, Hristakieva E, Solovastru LG, Patel RV, Giurcaneanu C, Hitova MC, Purcaru AI, Horia B, Tsingov II, Yankova RK, Kadurina MI, Ramon M, Rotaru M, Simionescu O, Benea V, Demerdjieva ZV, Cosgarea MR, Morariu HS, Michael Z, Cristodor P, Nica C, Silverman MH, Bristol DR, Harpaz Z, Farbstein M, Cohen S, Fishman P. David M, et al. Among authors: bristol dr. J Drugs Dermatol. 2016 Aug 1;15(8):931-8. J Drugs Dermatol. 2016. PMID: 27537992 Clinical Trial.
Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial.
Avni I, Garzozi HJ, Barequet IS, Segev F, Varssano D, Sartani G, Chetrit N, Bakshi E, Zadok D, Tomkins O, Litvin G, Jacobson KA, Fishman S, Harpaz Z, Farbstein M, Yehuda SB, Silverman MH, Kerns WD, Bristol DR, Cohn I, Fishman P. Avni I, et al. Among authors: bristol dr. Ophthalmology. 2010 Jul;117(7):1287-93. doi: 10.1016/j.ophtha.2009.11.029. Epub 2010 Mar 20. Ophthalmology. 2010. PMID: 20304499 Free PMC article. Clinical Trial.
Superior safety in noninferiority trials.
Bristol DR. Bristol DR. Biom J. 2005 Feb;47(1):75-81; discussion 99-107. doi: 10.1002/bimj.200410081. Biom J. 2005. PMID: 16395998
N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain.
Pomonis JD, Harrison JE, Mark L, Bristol DR, Valenzano KJ, Walker K. Pomonis JD, et al. Among authors: bristol dr. J Pharmacol Exp Ther. 2003 Jul;306(1):387-93. doi: 10.1124/jpet.102.046268. Epub 2003 Apr 29. J Pharmacol Exp Ther. 2003. PMID: 12721336
Clinical equivalence.
Bristol DR. Bristol DR. J Biopharm Stat. 1999 Nov;9(4):549-61. doi: 10.1081/bip-100101195. J Biopharm Stat. 1999. PMID: 10576403 Review.
p-value adjustments for subgroup analyses.
Bristol DR. Bristol DR. J Biopharm Stat. 1997 May;7(2):313-21; discussion 323-31. doi: 10.1080/10543409708835189. J Biopharm Stat. 1997. PMID: 9136072
22 results